Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of Naldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid Therapy

ClinicalTrials.gov ID: NCT01443403

Public ClinicalTrials.gov record NCT01443403. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of S-297995 for the Treatment of Opioid-Induced Constipation in Subjects With Non-Malignant Chronic Pain Receiving Opioid Therapy

Study identification

NCT ID
NCT01443403
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Shionogi
Industry
Enrollment
244 participants

Conditions and interventions

Interventions

  • Placebo Drug
  • Naldemedine Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 16, 2011
Primary completion
Aug 21, 2012
Completion
Aug 21, 2012
Last update posted
Jun 25, 2017

2011 – 2012

United States locations

U.S. sites
49
U.S. states
24
U.S. cities
49
Facility City State ZIP Site status
Shionogi Research Site Phoenix Arizona
Shionogi Research Site Sun Lakes Arizona
Shionogi Research Site Little Rock Arkansas
Shionogi Research Site Anaheim California
Shionogi Research Site Fresno California
Shionogi Research Site Lincoln California
Shionogi Research Site Lomita California
Shionogi Research Site Denver Colorado
Shionogi Research Site Brandon Florida
Shionogi Research Site Kissimmee Florida
Shionogi Research Site New Port Richey Florida
Shionogi Research Site North Miami Florida
Shionogi Research Site Ocala Florida
Shionogi Research Site Orlando Florida
Shionogi Research Site Ormond Beach Florida
Shionogi Research Site Port Orange Florida
Shionogi Research Site Sarasota Florida
Shionogi Research Site South Miami Florida
Shionogi Research Site West Palm Beach Florida
Shionogi Research Site Atlanta Georgia
Shionogi Research Site Decatur Georgia
Shionogi Research Site Marietta Georgia
Shionogi Research Site Evansville Indiana
Shionogi Research Site Lexington Kentucky
Shionogi Research Site Shreveport Louisiana
Shionogi Research Site Owings Mills Maryland
Shionogi Research Site Watertown Massachusetts
Shionogi Research Site Worcester Massachusetts
Shionogi Research Site Traverse City Michigan
Shionogi Research Site Edina Minnesota
Shionogi Research Site Las Vegas Nevada
Shionogi Research Site Newington New Hampshire
Shionogi Research Site Berlin New Jersey
Shionogi Research Site Willingboro New Jersey
Shionogi Research Site Hartsdale New York
Shionogi Research Site North Syracuse New York
Shionogi Research Site Williamsville New York
Shionogi Research Site Wilmington North Carolina
Shionogi Research Site Winston-Salem North Carolina
Shionogi Research Site Canton Ohio
Shionogi Research Site Columbus Ohio
Shionogi Research Site Perrysburg Ohio
Shionogi Research Site Eugene Oregon
Shionogi Research Site Philadelphia Pennsylvania
Shionogi Research Site Greer South Carolina
Shionogi Research Site Austin Texas
Shionogi Research Site Dallas Texas
Shionogi Research Site Orem Utah
Shionogi Research Site Salt Lake City Utah

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01443403, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 25, 2017 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01443403 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →